p-hydroxyamphetamine has been researched along with Cardiovascular Diseases in 1 studies
p-Hydroxyamphetamine: Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaynes, BI | 1 |
1 other study available for p-hydroxyamphetamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Monitoring drug safety; cardiac events in routine mydriasis.
Topics: Cardiovascular Diseases; Drug Combinations; Drug Monitoring; Eye Diseases; Heart; Humans; Mydriatics | 1998 |